Dalton, Greiner, Hartman, Maher & Co’s Orthofix Medical OFIX Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,910	Closed	-$343K	–	93
2021 Q1	$343K	Buy	+7,910	New	+$349K	0.27%	131
2020 Q3	–	Sell	-48,522	Closed	-$1.55M	–	172
2020 Q2	$1.55M	Sell	48,522 -280,158	-85%	-$9.3M	0.15%	155
2020 Q1	$9.21M	Sell	328,680 -96,173	-23%	-$3.72M	0.96%	31
2019 Q4	$19.6M	Buy	424,853 +89,407	+27%	+$4.2M	1.34%	14
2019 Q3	$17.8M	Buy	335,446 +33,137	+11%	+$1.71M	1.22%	21
2019 Q2	$16M	Buy	302,309 +105,575	+54%	+$5.62M	1.33%	25
2019 Q1	$11.1M	Buy	+196,734	New	+$11M	0.93%	48

Other funds holding OFIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's OFIX Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Orthofix Medical (OFIX) in Q2 2021, closing a stake of 7,910 shares — an estimated $343K sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in OFIX in Q1 2019 and held it in 7 quarters. The position peaked at $19.6M in Q4 2019. 134 funds tracked by Wall St. Rank hold OFIX as of Q2 2021.

Dalton, Greiner, Hartman, Maher & Co reported no remaining Orthofix Medical position as of Q2 2021 after selling out during the quarter.
Dalton, Greiner, Hartman, Maher & Co sold 7,910 Orthofix Medical shares in Q2 2021, an estimated $343K.
Dalton, Greiner, Hartman, Maher & Co first reported a position in Orthofix Medical in Q1 2019 and held it in 7 quarters.
Dalton, Greiner, Hartman, Maher & Co's Orthofix Medical position peaked at $19.6M in Q4 2019.
134 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.